Science Explorer Back to mapMap
Discussion
Researcher · Eli Lilly (Spain) · Spain

Ignacio Garcia‐Ribas

Ignacio Garcia‐Ribas publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.

ORCID 0009-0003-9911-7371 OpenAlex
World rank
#3,466,064
of 7,710,434 ranked researchers
Rank in Spain
#78,225
of 204,306
Works
70
Citations
927
Citations per work
13.2
h-index
13
i10-index 16Top 44% in Oncology

What does Ignacio Garcia‐Ribas research?

Ignacio Garcia‐Ribas's work is mostly in Medicine (56%), Immunology and Microbiology (10%), Biochemistry, Genetics and Molecular Biology (8%).

Life Sciences18%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3955.8%
  1. Everything else1826.1%
    1. Immunology and Microbiology710.1%
    2. Biochemistry, Genetics and Molecular Biology68.0%
  1. 1Oncology37% of their works
  2. 2Immunology10% of their works
  3. 3Molecular Biology8% of their works
  4. 4Pulmonary and Respiratory Medicine7% of their works
  5. 5Surgery6% of their works
  6. 6Radiology, Nuclear Medicine and Imaging6% of their works

Research topics

Which keywords describe Ignacio Garcia‐Ribas's research?

The keywords of their largest research topics: Chemotherapy, Chemotherapy-Induced Peripheral Neuropathy, Immune Checkpoint Blockade, PD-1 and PD-L1, Taxanes, Cetuximab, Dendritic Cells and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Chemotherapy193 topics
  2. Chemotherapy-Induced Peripheral Neuropathy111 topic
  3. Immune Checkpoint Blockade111 topic
  4. PD-1 and PD-L1111 topic
  5. Taxanes111 topic
  6. Cetuximab71 topic
  7. Dendritic Cells71 topic
  8. Immunity71 topic
  9. KRAS Mutations71 topic
  10. Bladder Cancer61 topic
  11. Breast Cancer61 topic
  12. HER261 topic
  13. Urothelial Carcinoma61 topic
  14. BRCA Mutation51 topic
  15. Cancer Genomics51 topic
  16. Mutational Signatures51 topic
  17. PARP Inhibitors51 topic

Where does Ignacio Garcia‐Ribas work?

Ignacio Garcia‐Ribas's main affiliation in the publication record is Eli Lilly (Spain), Spain.

How many publications and citations does Ignacio Garcia‐Ribas have?

OpenAlex counts 70 works and 927 citations for Ignacio Garcia‐Ribas, an h-index of 13, ranking #3,466,064 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ignacio Garcia‐Ribas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.